Fri, Aug 6, 2021
OPEN ACCESS
Volume 19, Issue 6 (November - December 2020)                   Payesh 2020, 19(6): 711-721 | Back to browse issues page

Ethics code: IR.ACECR.IBCRC.REC.1398.011


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Maftoon F, Aghasi M, Rafiee Bahabadi M, naghizadeh moghari F, montazeri A. A national campaign on ‘High Blood Pressure Control’ in Iran: A rapid evaluation. Payesh. 2020; 19 (6) :711-721
URL: http://payeshjournal.ir/article-1-1509-en.html
1- Health Metrics Research Center, Iranian Institute for Health Sciences Research, ACECR, Tehran, Iran
2- Iranian Students Polling Agency, ACECR, Tehran, Iran
Abstract:   (1163 Views)
Objective (s): Iranian Ministry of Health launched a national campaign to control high blood pressure among adult population in Iran. The campaign was consisted of two phases: raising awareness and filed action. This study was aimed to perform a rapid evaluation of the first phase of the campaign. The campaign was started from 17 May to 8 July 2019.
Methods: A cross sectional population study was conducted during the first phase of the campaign in order to find out the extent to which the campaign was successful in reaching the intended target population. A random sample of Iranian adults aged 18 and above were entered into the study and interviewed via telephone survey using a self-designed questionnaire including demographic information and items related to the campaign.
Results: In total a sample of 1526 Iranian adults were recruited and interviewed. The mean age of participants was 38.04 (SD = 12.9) years. Overall the findings showed that only 24.6% of participants (n = 376) heard about the campaign. Of these, only 167 individuals knew about the aim. However, performing logistic regression analysis the findings showed that higher age, being single, less education, and having a family without high blood pressure history were associated with lack of knowledge about the campaign while gender and living area (Urban vs. rural) were not.
Conclusion: The study findings suggest that to promote such campaigns there is need to develop appropriate strategies including formative and process evaluations at earlier stage of the campaign.
Full-Text [PDF 970 kb]   (275 Downloads)    
type of study: Research | Subject: Medical
Received: 2020/10/19 | Accepted: 2020/10/28 | ePublished ahead of print: 2020/11/15 | Published: 2020/12/20

References
1. Kontis V, et al, Regional contributions of six preventable risk factors to achieving the 25× 25 non-communicable disease mortality reduction target: a modelling study. Lancet Global Health 2015; 3: 746-757 [DOI:10.1016/S2214-109X(15)00179-5]
2. Collaboration N.R.F. Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants. International Journal of Epidemiology 2018; 47: 872-883
3. Mirzaei M, et al. Prevalence of hypertension in Iran 1980-2012: a systematic review. The Journal of Tehran University Heart Center 2016; 11: 159
4. Raised blood pressure (SBP ≥ 140 OR DBP ≥ 90), age-standardized (%) Estimates by WHO region. 2017. [2019.6.25].'Available from:' http://apps.who.int/gho/data/view.main.NCDBPAREGv?lang=en.
5. Sepanlou, S., et al., Hypertension and mortality in the Golestan Cohort Study: A prospective study of 50 000 adults in Iran. Journal of Human Hypertension 2016; 30: 260 [DOI:10.1038/jhh.2015.57]
6. BeaneyT, et al. May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension. European Heart Journal 2019; 40: 2006-2017 [DOI:10.1093/eurheartj/ehz300]
7. Safari Moradabadi A, Ghanbarnejad A, Nikparva M.r, Dadipoor S, Fallahi S, Prevalence of hypertension and respective risk factors in adults in Bandar Abbas, Iran. Medical Journal of Hormozgan University 2014; 18: 219-227 [Persian]
8. Fakhrzadeh Hussein, Hypertension: Prevention and Treatment Strategies (Preventive cardiology) (4). Tehran: New Medicine 2001. First Edition. [Persian]
9. Beaney T, et al, May Measurement Month 2017: an analysis of blood pressure screening results worldwide. The Lancet Global Health 2018; 6: 736-743 [DOI:10.1016/S2214-109X(18)30259-6]
10. Zohreh Kalani, Homa Abdi, Lili Shahbazi, Tahereh Salimi, Mohammad Reza Amini Poor. Hypertension in the Yazd adult population. Payesh 2011; 10:101-107[Persian]
11. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Roccella EJ. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. The Journal of the American Medical Association 2003; 289: 2560-71 [DOI:10.1001/jama.289.19.2560]
12. Ghorbani R, Askandarian R, Malek M, Rashidy-pour A. Prevalence of Hypertension among the Adult Population of Semnan Province. Iranian Journal of Endocrinology and Metabolism 2009; 10:495-503 [Persian]
13. Steiner, S., et al., Blood pressure awareness in Austria: lessons from a 30 years horizon. American Journal of Hypertension 2011; 24: 408-414 [DOI:10.1038/ajh.2010.257]
14. Sadghi M, Roohafza H, Asgary S, Sadry G, Bahonar A, Amani A et al . Prevalence of high blood pressure and its relation with cardiovascular risk factors. The Journal of Qazvin University of Medical Sciences 2003; 7: 46-52 [Persian]
15. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Circulation 2002; 106: 388-91 [DOI:10.1161/01.CIR.0000020190.45892.75]
16. Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel an Detection, Evaluation and Treatment of high Blood Cholesterol in adults (Adult Treatment Panel III). The Journal of the American Medical Association 2001; 285: 2486-97 [DOI:10.1001/jama.285.19.2486]
17. Pollock ML, Frankline BA, Balady GJ, et al. AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety and prescription: an advisory from the Committee on Exercise, Rehabilitation and Prevention, Council on Clinical Cardiology, American Heart Association; position paper and endorsed by the American College of Sport Medicine. Circulation 2000; 101: 828-33 [DOI:10.1161/01.CIR.101.7.828]
18. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: the evidence report. National Institutes of Health. Obesity Research 1998; 6: 51S-209S
19. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1999; 22: S5-S19 [DOI:10.2337/diacare.21.1.S5]
20. Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: a statement for health care professionals from the Stroke council of the American Heart Association. Circulation 2001; 103: 163-82 [DOI:10.1161/01.CIR.103.1.163]
21. Aspirin for the primary prevention of cardiovascular events: recommendations and rationale. US Preventive Services Task Force. Annals of Internal Medicine 2002; 136: 157-60 [DOI:10.7326/0003-4819-136-2-200201150-00015]
22. Preventing coronary heart disease in South Asia. Available in: http://heartfile. Org/saarc.htm.
23. Ghanbarian A, Madjid M, Rahmani M., Sarrafzadeh A, Azizi F. Distribution of blood pressure and prevalence of hypertension in Tehran adult population: tehran lipid and glucose study. Iranian Journal of Endocrinology and Metabolism 2004; 5: 425 -435 [Persian]
24. Subcommittee G. International Society of Hypertension. Guidline for the Management of Hypertension 1999 World Health Organization. Journal of Hypertension 1999; 17: 151-83 [DOI:10.1097/00004872-199917020-00001]
25. Chockalingam A, N.R. Campbell, and J.G. Fodor, Worldwide epidemic of hypertension. Canadian Journal of Cardiology 2006; 22: 553-555 [DOI:10.1016/S0828-282X(06)70275-6]
26. Seymour J, The impact of public health awareness campaigns on the awareness and quality of palliative care. Journal of Palliative Medicine 2018; 21: 30-36 [DOI:10.1089/jpm.2017.0391]
27. Mirzaei, M., et al., Awareness, treatment, and control of hypertension and related factors in adult Iranian population. BMC Public Health 2020; 20: 667 [DOI:10.1186/s12889-020-08831-1]
28. Paval A, Gheorghe-Fronea O, Iculae M. N, Acatrinei C, Petrisor C, Dorobantu M, Carol Davil. May measurement month-the relevance of national campaign awareness of arterial hypertension in Romania. Journal of Hypertension 2019; 37: e99 [DOI:10.1097/01.hjh.0000571288.55010.1b]
29. National Heart, Lung and Blood Institute: Public perceptions of high blood pressure and sodium. Public Health Reports. 1st Edition, NIH Publication; 1986
30. Centers for Disease Control and Prevention. National Center for Health Statistics [Internet]. National Health and Nutrition Examination Survey. Available from: http://www.cdc.gov/nchs/nhanes.htm.
31. Caligiuri S.P, J.A. Austria, and G.N. Pierce, Alarming prevalence of emergency hypertension levels in the general public identified by a hypertension awareness campaign. American Journal of Hypertension 2017; 30: 236-239 [DOI:10.1093/ajh/hpw136]
32. Kumar J. Epidemiology of hypertension. Clinical Queries: Nephrology 2013; 2: 56-61 [DOI:10.1016/j.cqn.2013.04.005]
33. Ahmadi, Zohreh, Izadkhah Fatemeh Sadat. A Study of the Role of Media in Community Health Development: A Review Study. the First Conference on Information Technology and Health Promotion 2018 Tehran, Information Technology and Health Promotion Association, https://www.civilica.com/Paper-THPC01-THPC01_108.html [Persian]
34. Razavi Tusi Seyed Mojtaba, Azarhamayoun Ramadan, Yahak Sajjad, Gholamipour Ismail. Creating health and medical messages in the media and its effect on public awareness. Bioethics 2015, 3: 77-43 [Persian]
35. Wee H., H Ho, and S. Li, Public awareness of diabetes mellitus in Singapore. Singapore Medical Journal 2002; 43: 128-134
36. Oto M.A, et al. Impact of a mass media campaign to increase public awareness of hypertension. Archives of the Turkish Society of Cardiology 2011; 39: 355-364 [DOI:10.5543/tkda.2011.01570]
37. Petrella R.J, et al. Impact of a social marketing media campaign on public awareness of hypertension American Journal of Hypertension 2005; 18: 270-5 [DOI:10.1016/j.amjhyper.2004.09.012]
38. Petrella R.J, et al. Does a public media campaign impact on hypertension awareness? American Journal of Hypertension 2001; 14: 146A-146A [DOI:10.1016/S0895-7061(01)01942-2]
39. Petrella R.J, et al., Does a public media campaign impact on hypertension awareness? American Journal of Hypertension 2001; 14: 146A-146A [DOI:10.1016/S0895-7061(01)01942-2]
40. Steckler AB, Linnan L, Israel B. Process evaluation for public health interventions and research. 1st Edition, CA: Jossey-Bass: San Francisco, 2002
41. Shams Mohsen. Social Marketing and Health Promotion - A New Perspective on Improving Health Behavior. http://healthpro.blogfa.com

Add your comments about this article : Your username or Email:
CAPTCHA

© 2021 All Rights Reserved | Payesh (Health Monitor)

Designed & Developed by : Yektaweb